Form 4: ICU Medical VP Virginia Sanzone Reports Stock Transactions
SEC Form 4 Filing
Virginia Sanzone, VP and General Counsel of ICU Medical, reports the acquisition and disposal of common stock and derivative securities, including restricted stock units and performance-based restricted stock units.
Summary
- Virginia Sanzone, VP and General Counsel of ICU Medical, filed a Form 4 detailing changes in beneficial ownership.
- On March 7 and 8, 2024, Sanzone engaged in multiple transactions involving ICU Medical's common stock and derivative securities.
- These transactions included the acquisition of 1,073 and 6,436 shares of common stock through the vesting of restricted stock units and performance-based restricted stock units (PRSUs) on March 7, 2024.
- Additionally, 2,273 shares of common stock were acquired through the vesting of performance-based restricted stock units (PRSUs) on March 8, 2024.
- Sanzone also disposed of shares to cover tax obligations, selling 587 shares on March 7, 2024, and 3,529 shares on the same day at a price of $105.39.
- On March 8, 2024, she sold 1,246 shares at $104.52 and 3,300 shares at a weighted average price of $104.5722.
- Following these transactions, Sanzone directly owns 5,798 shares of common stock.
- She also holds 1,073 restricted stock units and 9,568 performance shares.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
- The impact on employees, customers, suppliers, and creditors is likely to be negligible.
Key Dates
| Date | Description |
|---|---|
| 03/07/2022 | PRSUs were granted on this date and had a 2-year cliff-vest performance period subject to the satisfaction of performance-based metrics and continuous services through the vest date. |
| 03/08/2021 | PRSUs were granted on this date. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. |
| 03/07/2024 | Date of multiple transactions including acquisition and disposal of common stock and derivative securities. |
| 03/08/2024 | Date of multiple transactions including acquisition and disposal of common stock. |
| 03/11/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.